You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Life & Medical Care

Global Pediatrics Respiratory Drugs Market Insights and Forecast to 2026

Paediatric respiratory medicine (PRM) is a multidisciplinary subspecialty within the specialty of paediatrics, involving doctors, nurses, respiratory physiologists, physiotherapists, the child and the parent/caregiver.
Market Analysis and Insights: Global Pediatrics Respiratory Drugs Market
The global Pediatrics Respiratory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Pediatrics Respiratory Drugs Scope and Segment
Pediatrics Respiratory Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pediatrics Respiratory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
Valeant Pharmaceuticals
Merck
Endo International
Bauch & Lomb
Boehringer Ingelheim
Pediatrics Respiratory Drugs Breakdown Data by Type
Powder Inhalation
Oral
Pediatrics Respiratory Drugs Breakdown Data by Application
Hospitals
Clinics
Others
Regional and Country-level Analysis
The Pediatrics Respiratory Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pediatrics Respiratory Drugs market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Pediatrics Respiratory Drugs Market Share Analysis
1 Study Coverage
1.1 Pediatrics Respiratory Drugs Product Introduction
1.2 Market Segments
1.3 Key Pediatrics Respiratory Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pediatrics Respiratory Drugs Market Size Growth Rate by Type
1.4.2 Powder Inhalation
1.4.3 Oral
1.5 Market by Application
1.5.1 Global Pediatrics Respiratory Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Pediatrics Respiratory Drugs Market Size, Estimates and Forecasts
2.1.1 Global Pediatrics Respiratory Drugs Revenue 2015-2026
2.1.2 Global Pediatrics Respiratory Drugs Sales 2015-2026
2.2 Global Pediatrics Respiratory Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pediatrics Respiratory Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pediatrics Respiratory Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Pediatrics Respiratory Drugs Competitor Landscape by Players
3.1 Pediatrics Respiratory Drugs Sales by Manufacturers
3.1.1 Pediatrics Respiratory Drugs Sales by Manufacturers (2015-2020)
3.1.2 Pediatrics Respiratory Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Pediatrics Respiratory Drugs Revenue by Manufacturers
3.2.1 Pediatrics Respiratory Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Pediatrics Respiratory Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pediatrics Respiratory Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pediatrics Respiratory Drugs Revenue in 2019
3.2.5 Global Pediatrics Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pediatrics Respiratory Drugs Price by Manufacturers
3.4 Pediatrics Respiratory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Pediatrics Respiratory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pediatrics Respiratory Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Pediatrics Respiratory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pediatrics Respiratory Drugs Market Size by Type (2015-2020)
4.1.1 Global Pediatrics Respiratory Drugs Sales by Type (2015-2020)
4.1.2 Global Pediatrics Respiratory Drugs Revenue by Type (2015-2020)
4.1.3 Pediatrics Respiratory Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pediatrics Respiratory Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Pediatrics Respiratory Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Pediatrics Respiratory Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Pediatrics Respiratory Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pediatrics Respiratory Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Pediatrics Respiratory Drugs Market Size by Application (2015-2020)
5.1.1 Global Pediatrics Respiratory Drugs Sales by Application (2015-2020)
5.1.2 Global Pediatrics Respiratory Drugs Revenue by Application (2015-2020)
5.1.3 Pediatrics Respiratory Drugs Price by Application (2015-2020)
5.2 Pediatrics Respiratory Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Pediatrics Respiratory Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Pediatrics Respiratory Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Pediatrics Respiratory Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Pediatrics Respiratory Drugs by Country
6.1.1 North America Pediatrics Respiratory Drugs Sales by Country
6.1.2 North America Pediatrics Respiratory Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pediatrics Respiratory Drugs Market Facts & Figures by Type
6.3 North America Pediatrics Respiratory Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Pediatrics Respiratory Drugs by Country
7.1.1 Europe Pediatrics Respiratory Drugs Sales by Country
7.1.2 Europe Pediatrics Respiratory Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pediatrics Respiratory Drugs Market Facts & Figures by Type
7.3 Europe Pediatrics Respiratory Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Pediatrics Respiratory Drugs by Region
8.1.1 Asia Pacific Pediatrics Respiratory Drugs Sales by Region
8.1.2 Asia Pacific Pediatrics Respiratory Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pediatrics Respiratory Drugs Market Facts & Figures by Type
8.3 Asia Pacific Pediatrics Respiratory Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Pediatrics Respiratory Drugs by Country
9.1.1 Latin America Pediatrics Respiratory Drugs Sales by Country
9.1.2 Latin America Pediatrics Respiratory Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pediatrics Respiratory Drugs Market Facts & Figures by Type
9.3 Central & South America Pediatrics Respiratory Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Pediatrics Respiratory Drugs by Country
10.1.1 Middle East and Africa Pediatrics Respiratory Drugs Sales by Country
10.1.2 Middle East and Africa Pediatrics Respiratory Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pediatrics Respiratory Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Pediatrics Respiratory Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Mylan
11.1.1 Mylan Corporation Information
11.1.2 Mylan Description and Business Overview
11.1.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mylan Pediatrics Respiratory Drugs Products Offered
11.1.5 Mylan Related Developments
11.2 Armstrong Pharmaceuticals
11.2.1 Armstrong Pharmaceuticals Corporation Information
11.2.2 Armstrong Pharmaceuticals Description and Business Overview
11.2.3 Armstrong Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Products Offered
11.2.5 Armstrong Pharmaceuticals Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Pediatrics Respiratory Drugs Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Valeant Pharmaceuticals
11.4.1 Valeant Pharmaceuticals Corporation Information
11.4.2 Valeant Pharmaceuticals Description and Business Overview
11.4.3 Valeant Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Products Offered
11.4.5 Valeant Pharmaceuticals Related Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Description and Business Overview
11.5.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Merck Pediatrics Respiratory Drugs Products Offered
11.5.5 Merck Related Developments
11.6 Endo International
11.6.1 Endo International Corporation Information
11.6.2 Endo International Description and Business Overview
11.6.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Endo International Pediatrics Respiratory Drugs Products Offered
11.6.5 Endo International Related Developments
11.7 Bauch & Lomb
11.7.1 Bauch & Lomb Corporation Information
11.7.2 Bauch & Lomb Description and Business Overview
11.7.3 Bauch & Lomb Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bauch & Lomb Pediatrics Respiratory Drugs Products Offered
11.7.5 Bauch & Lomb Related Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Corporation Information
11.8.2 Boehringer Ingelheim Description and Business Overview
11.8.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Boehringer Ingelheim Pediatrics Respiratory Drugs Products Offered
11.8.5 Boehringer Ingelheim Related Developments
11.1 Mylan
11.1.1 Mylan Corporation Information
11.1.2 Mylan Description and Business Overview
11.1.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mylan Pediatrics Respiratory Drugs Products Offered
11.1.5 Mylan Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pediatrics Respiratory Drugs Market Estimates and Projections by Region
12.1.1 Global Pediatrics Respiratory Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Pediatrics Respiratory Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Pediatrics Respiratory Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Pediatrics Respiratory Drugs Sales Forecast (2021-2026)
12.2.2 North America: Pediatrics Respiratory Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Pediatrics Respiratory Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Pediatrics Respiratory Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Pediatrics Respiratory Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Pediatrics Respiratory Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Pediatrics Respiratory Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pediatrics Respiratory Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pediatrics Respiratory Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pediatrics Respiratory Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pediatrics Respiratory Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Pediatrics Respiratory Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Pediatrics Respiratory Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Pediatrics Respiratory Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Pediatrics Respiratory Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pediatrics Respiratory Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pediatrics Respiratory Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pediatrics Respiratory Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pediatrics Respiratory Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Pediatrics Respiratory Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pediatrics Respiratory Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Aug, 2020
  • NO OF PAGES: 134